Therapeutic Area

The future of data storage isn't on the cloud – it's on the 'edge'

The Independent

Time travel to the UK in 2025: Harry is a teenager with a smartphone and Pauline is a senior citizen with Alzheimer's who relies on smart glasses for independent living. Harry is frustrated his favourite online game is slow, and Pauline is anxious because her healthcare app is unresponsive. Forbes predicts that by 2025 more than 80 billion devices, from wearables and smartphones, to factory and smart-city sensors, will be connected to the internet. Something like 180 trillion gigabytes of data will be generated that year. Currently almost all data we generate is sent to and processed in distant clouds.

Chemical arms team to assign blame for Syrian attacks despite Russia, Iran opposition

The Japan Times

THE HAGUE, NETHERLANDS – The global chemical weapons watchdog will in February begin to assign blame for attacks with banned munitions in Syria's war, using new powers approved by member states but opposed by Damascus and its key allies Russia and Iran. The agency was handed the new task in response to an upsurge in the use of chemical weapons in recent years, notably in the Syrian conflict, where scores of attacks with sarin and chlorine have been carried out by Syrian forces and rebel groups, according to a joint United Nations-OPCW investigation. A core team of 10 experts charged with apportioning blame for poison gas attacks in Syria will be hired soon, Fernando Arias, the new head of the Organisation for the Prohibition of Chemical Weapons (OPCW), told the Foreign Press Association of the Netherlands on Tuesday. The Syria team will be able to look into all attacks previously investigated by the OPCW, dating back to 2014. The OPCW was granted additional powers to identify individuals and institutions responsible for attacks by its 193 member states at a special session in June.

AI toilets which scan your urine and faeces could one day 'pick up on diseases earlier'

Daily Mail

You may think the bathroom is one of few places you can expect to be left alone. But toilets may one day be giving health advice by analysing your urine and faeces, a technology boss has claimed. The chief of a company making computer chips says artificial intelligence will one day analyse people's waste in real time. This could save the need for trips to the doctor and pick up on illnesses earlier than people do, said Sanjay Mehrotra, chief executive of Micron Technology. AI could one day be used in toilets to scan people's urine and faeces to try and pick up on any diseases or health problems earlier than someone might notice them and go to the doctor And his claims aren't so far-fetched – artificial intelligence (AI) is already capable of detecting diabetes or Alzheimer's disease from scans.

The Genius Neuroscientist Who Might Hold the Key to True AI


When King George III of England began to show signs of acute mania toward the end of his reign, rumors about the royal madness multiplied quickly in the public mind. One legend had it that George tried to shake hands with a tree, believing it to be the King of Prussia. Another described how he was whisked away to a house on Queen Square, in the Bloomsbury district of London, to receive treatment among his subjects. The tale goes on that George's wife, Queen Charlotte, hired out the cellar of a local pub to stock provisions for the king's meals while he stayed under his doctor's care. More than two centuries later, this story about Queen Square is still popular in London guidebooks.

Advanced AI and big data methods to tackle dementia


Sports concussions, Parkinson's disease, and hormone therapy for cancer - all can have memory loss as symptoms. But do the biochemical processes of each type of memory loss have anything to reveal about the memory loss that is part of Alzheimer's disease? Rong Xu, PhD, recently received a total of $5 million for two projects that will use big data methods for a comprehensive look at a range of factors that may inform the mechanism of Alzheimer's and related dementia. "Vast amounts of data from seemingly unrelated sources present opportunities to researchers who aim to extract information that would help develop drugs or treatments," Says Xu, "This is especially true for diseases and conditions that may involve multiple genetic variations and that also have social or environmental influences." Xu is an associate professor at the Case Western Reserve University School of Medicine's Department of Population and Quantitative Health Sciences.

Here's what you need to know before going under the robo-knife

Daily Mail

First, you are strapped from the chest upwards on to the table, with your feet hoisted into stirrups. The table is swung down backwards, so you are tilted, head-down, at an angle of 45 degrees. Then a machine, known by some surgeons as'the 800lb gorilla', can get to work. It sounds so medieval, but this is the most modern of surgical techniques -- robotic surgery. The extraordinary posture, known as the steep Trendelenburg, is necessary to position the patient precisely so the robot arms can reach inside them.

Autism is an 'extreme version' of the male brain

Daily Mail

Autism is an extreme version of the'male brain' which makes it harder to read others' emotions, a major study suggests. The world's largest study comparing autism with male personality traits has found striking similarities. Men, like people with autism, are typically less good with feelings and more likely to want to know how things work. The world's largest study comparing autism with male personality traits has found striking similarities (stock) Compared to women, they tend to be more uneasy in social situations, less socially perceptive and may fail to understand why they have caused offence. Researchers at the University of Cambridge, who analysed personality tests for more than half a million men and women, found both men and autistic people were more'systematic' than'empathetic'.

What If AI Could Uber The Healthcare Industry?


I am never cleanly shaven. Or because I don't care about my appearance. Three years ago, I stopped shaving with water to conserve H20. It might seem like a little thing, but little things add up. When I tell people this, they sometimes scoff at me. "Oh, come on," they say.

Would you trust YOUR life to Artificial Intelligence?


Picture the scenario: a'robo-doc' Artificial Intelligence program has examined your scans, read your medical records, taken into account your habits, your genes, and crunched through global population data and the latest medical research. All this has allowed it to correctly identify an early-stage cancer long before it could ever become a true threat. All that's left is for your GP to deliver the news with skilled compassion. The doctor has ample time now, liberated by legions of automated systems that cut through a once-impossible workload. The hospital, should you ever need to attend, is now a model of efficiency with cleaners, nurses and doctors all guided by apps to wherever care is needed next.

Artificial intelligence to accelerate malaria research


IMAGE: InSilico study reveals how E64 approaches, binds to, and inhibits falcipain-2 of Plasmodium falciparum that causes malaria in humans. Monday, November 12, 2018, Taipei, Taiwan, Republic of China - Insilico Taiwan, a Taipei-based subsidiary of Insilico Medicine, developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, announces the publication of a new research paper titled "In Silico Study Reveals How E64 Approaches, Binds to, and Inhibits Falcipain-2 of Plasmodium falciparum that Causes Malaria in Humans" in Scientific Reports - a scientific journal published by the Nature Publishing Group. Malaria is one of the world's oldest infectious diseases that still causes a lot of health problems in many tropical countries. Plasmodium falciparum, the most dangerous human malaria parasite, is believed to cause hundreds of millions of illnesses and about half a million deaths a year. Inhibitors of FP2 block haemoglobin destruction and parasite development, suggesting that FP2 inhibition is a promising target for antimalarial therapy.